Patterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD
Autor: | Jacob B. Blumenthal, Anne Slaven, Rebecca M. Doerfler, Clarissa J. Diamantidis, Jonathan J. Taliercio, Eva Lustigova, Wolfgang C. Winkelmayer, Min Zhan, Chi-yuan Hsu, Corinne Woods, Louise Strauss, Wendy L. St. Peter, Jeffery C. Fink, Akinlolu O. Ojo, Dawei Xie, James P. Lash, Erin B. Mahone |
---|---|
Rok vydání: | 2017 |
Předmět: |
Adult
Male Nephrology medicine.medical_specialty Office Visits Epidemiology Analgesic 030232 urology & nephrology Renal function Self Medication Critical Care and Intensive Care Medicine Odds Young Adult 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Humans 030212 general & internal medicine Renal Insufficiency Chronic Aged Retrospective Studies Transplantation business.industry Anti-Inflammatory Agents Non-Steroidal Contraindications Drug Original Articles Odds ratio Middle Aged Confidence interval Discontinuation Analgesics Opioid Female Self Report business Glomerular Filtration Rate Cohort study |
Zdroj: | Clinical Journal of the American Society of Nephrology. 12:1778-1786 |
ISSN: | 1555-905X 1555-9041 |
DOI: | 10.2215/cjn.12311216 |
Popis: | Background and objectives Avoiding nonsteroidal anti-inflammatory drugs is important for safe CKD care. This study examined nonsteroidal anti-inflammatory drug use patterns and their association with other analgesic use in CKD. Design, setting, participants, & measurements The Chronic Renal Insufficiency Cohort Study is an observational cohort study that enrolled 3939 adults ages 21–74 years old with CKD between 2003 and 2008 using age-based eGFR inclusion criteria. Annual visits between June of 2003 and December of 2011 were organized into 15,917 visit-pairs (with an antecedent and subsequent visit) for 3872 participants with medication information. Demographics, kidney function, and clinical factors were ascertained along with report of nonsteroidal anti-inflammatory drug or other analgesic use in the prior 30 days. Results In our study, 24% of participants reported nonsteroidal anti-inflammatory drug use at baseline or at least one follow-up study visit. Having a 10 ml/min per 1.73 m 2 higher eGFR level at an antecedent visit was associated with higher odds of starting nonsteroidal anti-inflammatory drugs at a subsequent visit (odds ratio, 1.44; 95% confidence interval, 1.34 to 1.56). Seeing a nephrologist at the antecedent visit was associated with lower odds of starting or staying on nonsteroidal anti-inflammatory drugs at a subsequent visit (odds ratio, 0.70; 95% confidence interval, 0.56 to 0.87 and odds ratio, 0.61; 95% confidence interval, 0.46 to 0.81, respectively). Starting and stopping nonsteroidal anti-inflammatory drugs were both associated with higher odds of increasing the number of other analgesics (odds ratio, 1.52; 95% confidence interval, 1.25 to 1.85 and odds ratio, 1.78; 95% confidence interval, 1.39 to 2.28, respectively) and higher odds of increasing the number of opioid analgesics specifically (odds ratio, 1.92; 95% confidence interval, 1.48 to 2.48 and odds ratio, 1.46; 95% confidence interval, 1.04 to 2.03, respectively). Conclusions Nonsteroidal anti-inflammatory drug use is common among patients with CKD but less so among those with worse kidney function or those who see a nephrologist. Initiation or discontinuation of nonsteroidal anti-inflammatory drugs is often associated with supplementation with or replacement by, respectively, other analgesics, including opioids, which introduces possible drug-related problems when taking these alternative analgesics. |
Databáze: | OpenAIRE |
Externí odkaz: |